TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Standard Catheter Directed Thrombolysis vs. Ultrasound Assisted Thrombolysis for Patients With Acute Submassive Pulmonary Embolism
Brief Summary: The study will compare standard catheter directed thrombolysis to ultrasound accelerated thrombolysis for the treatment of acute submassive pulmonary embolism (PE). The study population will include patients eligible for catheter directed thrombolysis (CDT) for submassive PE. Subjects will be randomized to, either, standard catheter-directed thrombolysis or ultrasound-accelerated thrombolysis (USAT).


Options:
A: Arm Label: CDT without ultrasound acceleration; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CDT without ultrasound acceleration | Arm Label: CDT ultrasound accelerated; Type: EXPERIMENTAL; Interventions: Procedure: CDT with ultrasound acceleration | Intervention Type: PROCEDURE; Name: CDT without ultrasound acceleration; Assigned to Arm(s): CDT without ultrasound acceleration | Intervention Type: PROCEDURE; Name: CDT with ultrasound acceleration; Assigned to Arm(s): CDT ultrasound accelerated
B: Arm Label: Single Arm; Type: OTHER; Interventions: Device: Indigo Aspiration System | Intervention Type: DEVICE; Name: Indigo Aspiration System; Assigned to Arm(s): Single Arm
C: Arm Label: A-Intervention; Type: EXPERIMENTAL; Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA) | Arm Label: B-Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Recombinant tissue plasminogen activator (rt-PA); Assigned to Arm(s): A-Intervention
D: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.9% Saline + Enoxaparin | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Tenecteplase + Enoxaparin | Intervention Type: DRUG; Name: Tenecteplase + Enoxaparin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: 0.9% Saline + Enoxaparin; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of C-reactive Protein Testing on Antibiotic Prescription in Febrile Patients Attending Primary Care in Low-resource Settings
Brief Summary: PRIMARY OBJECTIVE To assess the impact of C-reactive protein (CRP) Point-of-care (POC) testing on health care worker prescribing behaviour in patients presenting to primary healthcare centres with an acute fever or recent history of fever.

SECONDARY OBJECTIVES To assess the impact of CRP testing on clinical outcomes within the 14 days of follow-up.

To assess the correlation between CRP results and clinical outcomes on the day 5 of the enrolment.

To estimate the impact of CRP testing on antibiotic consumption after first consultation.

To explore the attitudes of health centre staff towards the POC CRP test. To identify the prevalence of key pathogens in febrile patients in these settings.

To validate the ability of CRP to discriminate between viral and bacterial pathogens in a subset of patients with a microbiologically confirmed diagnosis.


Options:
A: Arm Label: PCT guidance; Type: OTHER; Interventions: Other: the procalcitonin arm | Arm Label: clinical reassessment; Type: OTHER; Interventions: Other: the clinical reassessment arm | Intervention Type: OTHER; Name: the clinical reassessment arm; Assigned to Arm(s): clinical reassessment | Intervention Type: OTHER; Name: the procalcitonin arm; Assigned to Arm(s): PCT guidance
B: Arm Label: Pre-consultation CRP; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Pre-consultation CRP | Arm Label: CRP requested; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Pre-consultation CRP; Assigned to Arm(s): Pre-consultation CRP
C: Arm Label: CRP-Control; Type: OTHER; Interventions: Other: No CRP will be measured onsite | Arm Label: CRP-A; Type: OTHER; Interventions: Other: CRP cut-off of 20mg/L. | Arm Label: CRP-B; Type: OTHER; Interventions: Other: CRP cut-off of 40mg/L. | Intervention Type: OTHER; Name: No CRP will be measured onsite; Assigned to Arm(s): CRP-Control | Intervention Type: OTHER; Name: CRP cut-off of 20mg/L.; Assigned to Arm(s): CRP-A | Intervention Type: OTHER; Name: CRP cut-off of 40mg/L.; Assigned to Arm(s): CRP-B
D: Intervention Type: OTHER; Name: laboratory value procalcitonin; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does the Addition of Dexamethasone to a Local Infiltration Analgesia Mixture Improve Functional Outcomes Following Total Joint Arthroplasty?
Brief Summary: This study will evaluate if the addition of dexamethasone to a local infiltration analgesia mixture will improve functional outcomes following total hip and knee arthroplasty.


Options:
A: Arm Label: Dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone, Drug: Morphine, Drug: Zofran, Drug: Paracetamol, Drug: Ibuprofen | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo, Drug: Morphine, Drug: Zofran, Drug: Paracetamol, Drug: Ibuprofen | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Dexamethasone, Placebo | Intervention Type: DRUG; Name: Zofran; Assigned to Arm(s): Dexamethasone, Placebo | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Dexamethasone, Placebo | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Dexamethasone, Placebo
B: Arm Label: Dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone, Drug: LIA Combination Mixture | Arm Label: Saline; Type: SHAM_COMPARATOR; Interventions: Other: 0.9% NaCl Placebo, Drug: LIA Combination Mixture | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: OTHER; Name: 0.9% NaCl Placebo; Assigned to Arm(s): Saline | Intervention Type: DRUG; Name: LIA Combination Mixture; Assigned to Arm(s): Dexamethasone, Saline
C: Arm Label: The study group (Gr. D); Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone, Drug: Ondansetron | Arm Label: the control group (Gr. N); Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.9% Sodium Chloride Injection | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): The study group (Gr. D) | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): The study group (Gr. D) | Intervention Type: DRUG; Name: 0.9% Sodium Chloride Injection; Assigned to Arm(s): the control group (Gr. N)
D: Arm Label: Treatment A:; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: Treatment B:; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone, Drug: Placebos | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebos | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Treatment A:, Treatment B: | Intervention Type: DRUG; Name: Placebos; Assigned to Arm(s): Placebo, Treatment B:

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-blind Randomized Controlled Clinical Trial of 3 Days of Amoxicillin Disperable Tablet (DT) Versus Placebo for Fast Breathing Childhood Pneumonia Among Children 2-59 Months of Age Presenting to Kamuzu Central Hospital in Lilongwe, Malawi
Brief Summary: The purpose of this study to assess the effectiveness of no antibiotic treatment for fast breathing, community-acquired childhood pneumonia in a malaria-endemic region of Malawi.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Motavizumab; Type: ACTIVE_COMPARATOR; Interventions: Biological: Motavizumab | Intervention Type: BIOLOGICAL; Name: Motavizumab; Assigned to Arm(s): Motavizumab | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Treated; Type: N/A; Interventions: N/A | Arm Label: Untreated; Type: N/A; Interventions: N/A
C: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Arm Label: 3 Days; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): 3 Days | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Amoxycillin; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectivity of Differences Therapies on Central Nerve System for Pain, Phantom, Disability and Quality of Life in Amputees
Brief Summary: This study evaluates the effectiveness of imagery motor on phantom pain and amputation process


Options:
A: Arm Label: Treatment Traditional and Motor Imaginary Program; Type: EXPERIMENTAL; Interventions: Other: Treatment Traditional and Imaginary Motor Program | Arm Label: Treatment Traditional and Mirror Therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment Traditional and Mirror Therapy | Intervention Type: OTHER; Name: Treatment Traditional and Imaginary Motor Program; Assigned to Arm(s): Treatment Traditional and Motor Imaginary Program | Intervention Type: OTHER; Name: Treatment Traditional and Mirror Therapy; Assigned to Arm(s): Treatment Traditional and Mirror Therapy
B: Arm Label: Virtual reality gait rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Virtual Reality Gait Training | Arm Label: Treadmill training gait rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Treadmill Gait Training | Intervention Type: OTHER; Name: Virtual Reality Gait Training; Assigned to Arm(s): Virtual reality gait rehabilitation | Intervention Type: OTHER; Name: Treadmill Gait Training; Assigned to Arm(s): Treadmill training gait rehabilitation
C: Arm Label: Physio Therapy; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: Virtual Reality; Type: EXPERIMENTAL; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Physio Therapy, Virtual Reality
D: Arm Label: Cognitive Games; Type: ACTIVE_COMPARATOR; Interventions: Device: Wii Big Brain Academy Degree program | Arm Label: WiiNWALK Intervention; Type: EXPERIMENTAL; Interventions: Device: Nintendo Wii | Intervention Type: DEVICE; Name: Nintendo Wii; Assigned to Arm(s): WiiNWALK Intervention | Intervention Type: DEVICE; Name: Wii Big Brain Academy Degree program; Assigned to Arm(s): Cognitive Games

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Breathe Well Program to Improve Asthma Outcomes
Brief Summary: The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.


Options:
A: Arm Label: IVR call/text; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: IVR call/text | Arm Label: Email; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Email | Intervention Type: BEHAVIORAL; Name: IVR call/text; Assigned to Arm(s): IVR call/text | Intervention Type: BEHAVIORAL; Name: Email; Assigned to Arm(s): Email
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Web-based Asthma Management | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Generic web-based asthma education | Intervention Type: BEHAVIORAL; Name: Tailored Web-based Asthma Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Generic web-based asthma education; Assigned to Arm(s): 2
C: Arm Label: Case Group; Type: N/A; Interventions: N/A | Arm Label: Control Group; Type: N/A; Interventions: Other: MyMediHealth access | Intervention Type: OTHER; Name: MyMediHealth access; Assigned to Arm(s): Control Group
D: Arm Label: End User Iterative Testing - CampAir; Type: OTHER; Interventions: Behavioral: CampAir | Intervention Type: BEHAVIORAL; Name: CampAir; Assigned to Arm(s): End User Iterative Testing - CampAir

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicenter Randomized Prevention Trial of Recurrence of Suicide Attempt by Adolescent by Sending SMS (MEDIACONNEX)
Brief Summary: MEDIACONNEX study propose a new way of connectedness for adolescents after a suicide attempt: it is based on the sending of SMS (or mail or other new media), over a period of 6 months after their suicide attempt (SA), in order to allow them to recourse to the care more easily and so to limit the risk of suicidal recurrence. The MEDIACONNEX study will be a multicenter controlled randomized trial (East of France) and there is a funding from the Hospital. The proposal trial will test the hypothesis that adolescent suicide attempters who are receiving SMS (or mail or other new media) from the unit of care in addition to the usual care will do less SA recurrence, than those who are receiving the usual care.

The primary objective is to determine whether the use of SMS (or mail or other new media) to keep in touch with adolescent suicide attempters in addition to the usual care, compare to usual care, will reduce the delay of recurrence of suicide attempt during 6 months after the SA.


Options:
A: Arm Label: Youth-Nominated Support Team; Type: EXPERIMENTAL; Interventions: Behavioral: Youth-Nominated Support Team | Arm Label: Enhanced Treatment as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Youth-Nominated Support Team; Assigned to Arm(s): Youth-Nominated Support Team
B: Arm Label: Decision Aid Group; Type: EXPERIMENTAL; Interventions: Behavioral: Decision Aid | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Decision Aid; Assigned to Arm(s): Decision Aid Group
C: Arm Label: Diaclectical Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Therapy | Arm Label: Support Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Therapy | Arm Label: Controls; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral Therapy; Assigned to Arm(s): Diaclectical Behavioral Therapy, Support Therapy
D: Arm Label: MEDIA; Type: EXPERIMENTAL; Interventions: Other: MEDIA | Arm Label: CLASSIC; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: MEDIA; Assigned to Arm(s): MEDIA

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicenter Randomized Prevention Trial of Recurrence of Suicide Attempt by Adolescent by Sending SMS (MEDIACONNEX)
Brief Summary: MEDIACONNEX study propose a new way of connectedness for adolescents after a suicide attempt: it is based on the sending of SMS (or mail or other new media), over a period of 6 months after their suicide attempt (SA), in order to allow them to recourse to the care more easily and so to limit the risk of suicidal recurrence. The MEDIACONNEX study will be a multicenter controlled randomized trial (East of France) and there is a funding from the Hospital. The proposal trial will test the hypothesis that adolescent suicide attempters who are receiving SMS (or mail or other new media) from the unit of care in addition to the usual care will do less SA recurrence, than those who are receiving the usual care.

The primary objective is to determine whether the use of SMS (or mail or other new media) to keep in touch with adolescent suicide attempters in addition to the usual care, compare to usual care, will reduce the delay of recurrence of suicide attempt during 6 months after the SA.


Options:
A: Arm Label: Post Admission Cognitive Therapy (PACT); Type: EXPERIMENTAL; Interventions: Behavioral: Post Admission Cognitive Therapy (PACT) | Arm Label: Enhanced Usual Care (EUC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Post Admission Cognitive Therapy (PACT); Assigned to Arm(s): Post Admission Cognitive Therapy (PACT)
B: Arm Label: Presence of SUD with BCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Presence of SUD with TAU; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Absence of SUD with BCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Absence of SUD with TAU; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Absence of SUD with BCBT, Presence of SUD with BCBT
C: Arm Label: MEDIA; Type: EXPERIMENTAL; Interventions: Other: MEDIA | Arm Label: CLASSIC; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: MEDIA; Assigned to Arm(s): MEDIA
D: Arm Label: Brief Admission; Type: EXPERIMENTAL; Interventions: Other: Brief Admission | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Brief Admission; Assigned to Arm(s): Brief Admission

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy
Brief Summary: The investigators intend to conduct multi-center randomized controlled study to find if Uncut Roux-en-Y anastomosis to the distal gastric cancer patients after radical D2 can reduce the long-term complications, affect the quality of life, and improve the prognosis, comparing to Billroth II anastomosis.


Options:
A: Arm Label: the group of Roux-en-Y; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Roux-en-Y reconstruction | Arm Label: the group of Uncut Roux-en-Y; Type: EXPERIMENTAL; Interventions: Procedure: Uncut Roux-en-Y reconstruction | Intervention Type: PROCEDURE; Name: Uncut Roux-en-Y reconstruction; Assigned to Arm(s): the group of Uncut Roux-en-Y | Intervention Type: PROCEDURE; Name: Roux-en-Y reconstruction; Assigned to Arm(s): the group of Roux-en-Y
B: Arm Label: Billroth-I; Type: EXPERIMENTAL; Interventions: Procedure: Billroth-I | Arm Label: Roux en Y; Type: EXPERIMENTAL; Interventions: Procedure: Roux en Y | Intervention Type: PROCEDURE; Name: Billroth-I; Assigned to Arm(s): Billroth-I | Intervention Type: PROCEDURE; Name: Roux en Y; Assigned to Arm(s): Roux en Y
C: Arm Label: Uncut Roux-en-Y Reconstruction; Type: EXPERIMENTAL; Interventions: Procedure: Uncut Roux-en-Y Reconstruction | Arm Label: Billroth II Reconstruction; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Billroth II Reconstruction | Intervention Type: PROCEDURE; Name: Uncut Roux-en-Y Reconstruction; Assigned to Arm(s): Uncut Roux-en-Y Reconstruction | Intervention Type: PROCEDURE; Name: Billroth II Reconstruction; Assigned to Arm(s): Billroth II Reconstruction
D: Arm Label: uncut Roux-en-Y anastomosis; Type: EXPERIMENTAL; Interventions: Procedure: Uncut Roux-en-Y anastomosis | Arm Label: Billroth II anastomosis; Type: SHAM_COMPARATOR; Interventions: Procedure: Billroth II anastomosis | Intervention Type: PROCEDURE; Name: Uncut Roux-en-Y anastomosis; Assigned to Arm(s): uncut Roux-en-Y anastomosis | Intervention Type: PROCEDURE; Name: Billroth II anastomosis; Assigned to Arm(s): Billroth II anastomosis

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Indwelling vs Immediate Removal of Foley Catheter After Robotic Assisted Laparoscopic Sacrocolpopexy: a Prospective Study
Brief Summary: This is a prospective, comparative randomized study. Our study population includes women with pelvic organ prolapse undergoing a robotic assisted laparoscopic sacrocolpopexy.

The two groups will include the study group, who will have their Foley catheter removed 6 hours post-op, and the control group who will have an indwelling Foley catheter overnight. The two groups will be assigned according REDCap randomization system.


Options:
A: Arm Label: Foley; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: No Foley; Type: ACTIVE_COMPARATOR; Interventions: Other: No Foley | Intervention Type: OTHER; Name: No Foley; Assigned to Arm(s): No Foley
B: Arm Label: Autofill Void Trial; Type: ACTIVE_COMPARATOR; Interventions: Device: Void Trial using Foley catheter | Arm Label: Backfill Void Trial; Type: ACTIVE_COMPARATOR; Interventions: Device: Void Trial using Foley catheter | Intervention Type: DEVICE; Name: Void Trial using Foley catheter; Assigned to Arm(s): Autofill Void Trial, Backfill Void Trial
C: Arm Label: Drotaverine; Type: N/A; Interventions: N/A | Arm Label: Control; Type: N/A; Interventions: N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: postoperative catheterization | Arm Label: 2.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: postoperative catheterization | Intervention Type: PROCEDURE; Name: postoperative catheterization; Assigned to Arm(s): 1, 2.

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Guided Versus Directed Training in Acute Stroke Rehabilitation
Brief Summary: Individuals with cognitive impairments after stroke sustain significant disability in their daily tasks, and account for a significant proportion of stroke-related healthcare costs. This loss of independence is costly because individuals with stroke-related cognitive impairments require more rehabilitation and more resources to support their living, whether in institutional or community settings. The proposed study examines the effects of directed and guided training on the recovery of independence with daily activities in adults with stroke-related cognitive impairments in acute rehabilitation. The investigators predict that patients in both groups will demonstrate significant improvement in independence with daily activities in the first 12 months after rehabilitation admission, but that patients who receive guided training will demonstrate significantly more improvements than patients who received directed training.


Options:
A: Arm Label: CO-OP; Type: EXPERIMENTAL; Interventions: Behavioral: CO-OP | Arm Label: Standard Occupational Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Occupational Therapy | Intervention Type: BEHAVIORAL; Name: CO-OP; Assigned to Arm(s): CO-OP | Intervention Type: BEHAVIORAL; Name: Standard Occupational Therapy; Assigned to Arm(s): Standard Occupational Therapy
B: Arm Label: OPC-Stroke, Usual care; Type: EXPERIMENTAL; Interventions: Other: OPC-Stroke, Other: Usual care | Arm Label: Usual care; Type: OTHER; Interventions: Other: Usual care | Intervention Type: OTHER; Name: OPC-Stroke; Assigned to Arm(s): OPC-Stroke, Usual care | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): OPC-Stroke, Usual care, Usual care
C: Arm Label: Rhythm and music therapy; Type: EXPERIMENTAL; Interventions: Other: RGRM | Arm Label: Therapeutic riding; Type: ACTIVE_COMPARATOR; Interventions: Other: Therapeutic riding | Arm Label: Receives no intervention; Type: OTHER; Interventions: Other: Receives no intervention | Intervention Type: OTHER; Name: RGRM; Assigned to Arm(s): Rhythm and music therapy | Intervention Type: OTHER; Name: Therapeutic riding; Assigned to Arm(s): Therapeutic riding | Intervention Type: OTHER; Name: Receives no intervention; Assigned to Arm(s): Receives no intervention
D: Arm Label: Guided Training; Type: EXPERIMENTAL; Interventions: Behavioral: Guided Training | Arm Label: Directed Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Directed Training | Intervention Type: BEHAVIORAL; Name: Guided Training; Assigned to Arm(s): Guided Training | Intervention Type: BEHAVIORAL; Name: Directed Training; Assigned to Arm(s): Directed Training

Answer: D